Is BioNexus Gene Lab Corp. (BGLC) a Buy, Sell, or Hold?
NASDAQ : BGLC
BioNexus Gene Lab Corp. — Insider Trades
$1.51 USD
-$0.03 (-1.95%)
- Volume
- 4.75K
- Average Volume
- 99.31K
- Market Capitalization
- $3.04M
- P/E Ratio
- -1.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.98
- Year Low
- $1.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.52
Insider Activity Summary (Last 12 Months)
Insiders Buying
0
Insiders Selling
0
Amount of Insider Selling
-$
BGLC Insider Buying/Selling by Quarter
BGLC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Wong Yee Meng | 2023-07-19 | 0 | 2023-10-04 | ||
| Yap Chee Keong | 2023-07-19 | 0 | 2023-10-04 | ||
| Yew Chak Hua | 2023-07-19 | 0 | 2023-10-04 | ||
| Lin Chai Ping | 2023-07-19 | 0 | 2023-10-04 | ||
| Teoh Boon Teong | 2023-07-19 | 0 | 2023-10-04 | ||
| Fong Yeat Min | 2023-07-19 | 0 | 2023-10-04 | ||
| Yeoh Sook Keng | 2023-07-19 | 0 | 2023-10-04 | ||
| Leong Wei Li | officer: Chief Financial Officer | 2023-07-19 | 0 | 2023-10-04 | |
| Liong Tai Tan | director, officer: Chief Operating Officer | 2023-07-19 | 0 | 2023-10-04 | |
| Fong Teng Fook | 2023-07-19 | 0 | 2023-10-04 |